Medintech, a KERI Startup, Launches 22.8 Billion Won National Project with Seoul National University, Seoul National University Hospital, and DGIST

AI Autonomous Steering and Ultra-Precise Treatment Automation

“Overcoming 50 Years of Manual Endoscope Limitations”

A home ‘dream workforce’ from business, academia, analysis institutes, and hospitals has set its sights on the international versatile endoscope market, the place Japanese firms maintain greater than 95% market share. With the growth of next-generation robotic endoscopes that includes synthetic intelligence (AI)-based autonomous steering and ultra-precise therapy expertise, curiosity is rising in the prospects for localizing medical gadgets and getting into the international market.

On June 7, the Korea Electrotechnology Research Institute (KERI) introduced that Medintech Co., Ltd., a startup based on KERI expertise, will collaborate with Seoul National University Hospital, Seoul National University, Daegu-Gyeongbuk Institute of Science and Technology (DGIST), and KERI itself on the mission titled “Development of a Next-Generation Intelligent Robotic Endoscope Platform with AI-Based Autonomous Steering and Ultra-Precise Surgical Automation Technology.”


Soft electronic endoscope equipment of Medintech Co., Ltd., a technology startup company at KERI. Provided by KERI

Soft digital endoscope tools of Medintech Co., Ltd., a expertise startup firm at KERI. Provided by KERI


View original image

This mission is a part of the pan-ministerial Advanced Medical Device Research and Development Program, and a complete of twenty-two.8 billion gained in analysis funding can be invested from April 2024 by means of December 2031.

Currently, the versatile digital endoscope marketplace for gastric and colorectal most cancers screening is just about monopolized by Japanese firms comparable to Olympus, Pentax, and Fujifilm. The standard technique, the place medical workers manually function a dial, has remained unchanged for many years, resulting in issues about various diagnostic high quality and affected person discomfort relying on the examiner’s stage of expertise.

The analysis workforce plans to combine AI into Medintech’s present motorized endoscope expertise to comprehend “AI autonomous steering,” which allows the endoscope to independently discover and observe the optimum path. The objective is to shorten examination occasions, cut back affected person discomfort, and standardize examination high quality.

The analysis scope will prolong past diagnostic endoscopes to the therapy area. The workforce plans to develop robotics expertise that allows high-level procedures comparable to gripping, traction, incision, and suturing of lesions, by creating ultra-miniature, multi-joint surgical devices that may transfer freely inside slim inside organs, in addition to addressing specialised endoscope fields comparable to duodenoscopes and cholangioscopes.


Scope, a flexible electronic endoscope used for observing lesions and diagnosing and treating them. Provided by KERI

Scope, a versatile digital endoscope used for observing lesions and diagnosing and treating them. Provided by KERI


View original image

Each establishment’s function has additionally been specified. Medintech Co., Ltd. will oversee the growth of the clever motorized robotic endoscope platform, whereas Seoul National University Hospital will conduct scientific trials and expertise validation. Seoul National University will develop AI algorithms for diagnostic and surgical help, KERI can be accountable for optical and picture processing expertise, and DGIST will concentrate on core robotic endoscope drive applied sciences.

Bae Youngmin, Head of the Medical Electronic Device Research Division at KERI, acknowledged, “By combining the institute’s accumulated core technologies in electronic endoscopy with the collective capabilities of industry, academia, research, and medical sectors, we aim to build an innovative, domestically produced robotic endoscope platform that can surpass the current global monopoly. We hope this project will become a leading example of commercializing research achievements through spin-off companies.”

Kim Namgyun, President of KERI, emphasised, “We will actively support efforts to prove the competitiveness of domestic technology in the global medical endoscope market, which is projected to grow to approximately 41.1 billion dollars by 2034.”

This content material was produced with the help of AI translation providers.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.



Sources

Leave a Reply

Your email address will not be published. Required fields are marked *